Introduction
A large body of epidemiological and experimental data has demonstrated a direct link between chronic inflammation and complex diseases such as obesity, allergy, asthma, cardiovascular disease, type 2 diabetes, rheumatoid arthritis, bowel disease and several types of cancer. Nutrition, as the main aspect of the environment, is said to play a key role in some of this disparities, however, the molecular mechanisms involved still remain to be unraveled [1] [2] [3] . Genome-wide association studies have identified hundreds of genetic variants associated with complex human diseases and traits, and have provided valuable insights into their genetic architecture. However, most variants identified so far confer relatively small increments in risk, leaving many questions how the remaining "missing" heritability can be explained, although polygenic disease traits may account for some of this limitations [4, 5] .
Furthermore, genetics per se cannot explain the vast diversity of phenotypes. A substantial number of studies have shown that contstraint in the early life environment is associated with increased risk of cardiometabolic disease, affective disorders and cognitive decline, osteoporosis, allergy, inflammation and specific cancers. Furthermore, genetics per se cannot explain the vast diversity of phenotypes. The differences between identical twins and their different susceptibility to most diseases has recently been attributed to epigenetic changes which accumulate during life following exposure to different environmental conditions [6] [7] [8] .
The contribution of epigenetic changes (epimutations) to human disease is probably underestimated. Epigenetics encompasses several extra-genetic processes such as DNA methylation (methylation of cytosines within CpG dinucleotides), histone tail modifications (including acetylation, phosphorylation, methylation, sumoylation, ribosylation and ubiquitination), noncoding RNA functions, regulation of polycomb group proteins and the epigenetic cofactor modifiers, all of which may alter gene expression but do not involve changes in the DNA sequence itself [9] [10] [11] [12] [13] . The combinatorial nature of DNA methylation and histone modifications significantly extends the information potential of the genetic code.
In a large scale comparative study, authors concluded a lack of genetic factor in chronic obstructive pulmonary disorder (COPD), cardiovascular disease (CVD), rheumatoid arthritis and Crohn's disease, all typical examples of diseases with an important inflammatory component [14] . A recent survey of the global incidence of cancer shows that the age-adjusted cancer incidence in the Western world is above 300 cases per 100,000 population, whereas that in Asian countries is less than 100 cases per 100,000. Sedentary lifestyle, diet, obesity and metabolic syndrome have been named as the major contributors to this phenomena, which is further emphasized by the increase in cancer cases among immigrants from Asian to 5 be twiddled by various volume knobs. Considerable cross-talk occurs between three main players in silencing: DNA methylation, histone modifications and noncoding RNAs. The chromatin template therefore serves as the major platform for epigenetic regulation in the form of DNA methylation, histone modifications and histone variants. More recently, an epigenetic role for RNA has also been demonstrated in normal situations as well as in disease [12] . Before most activators of a gene access their DNA-binding sites, a transition from a condensed ("solenoid-like fiber") to a decondensed ("beads on a string") chromatin structure appears to take place. Conversely, the acquisition of a more condensed chromatin structure is often associated with gene silencing [11] . This structural restriction of chromatin on gene expression can be overcome by chromatin remodeling cofactor complexes, which reversibly modify (acetylation, phosphorylation, ubiquitylation, glycosylation, sumoylation) on lysine, arginistine, serine or threonine residues of amino-terminal histone tails. In general, DNA is wrapped around nucleosomes, which are arranged as regularly spaced beads (146 bp DNA/nucleosome) along the DNA. Typically, nucleosomes consist of a histone octamer of histones (H)2A/B, H3 and H4. The DNA bridging two adjacent nucleosomes is normally bound by the linker histone H1 and is termed linker DNA. While the core histones are bound relatively tightly to DNA, chromatin is largely maintained by the dynamic association with its architectural proteins. Since the discovery of histone modifying enzymes, N-terminal histone tails protruding from nucleosomes were found to be 'velcro patches' for (de)acetylases (HDAC/HAT), (de)methylases (HMT/HDMT), ubiquitin ligases, small ubiquitin-related modifier (SUMO) ligases, kinases, phosphatases, ribosylases, which together establish specific histone modification patterns involved in transcription [11] . Specific sets of histone modifications and/or variants are associated with genes that are actively transcribed or are repressed, a phenomenon defined as the "histone code" [11] . Since the modifications do not involve underlying changes in nucleotide or amino acid sequences, they are "above the genome" and as such termed "epigenomic". However, to establish specificity of epigenetic marks, histone modifying complexes have to be recruited to relevant genomic locations by DNA-binding proteins, RNAs or protein-RNA complexes that bind to their specific DNA sites as a consequence of their own binding specificities and cellular concentrations [43] [44] [45] [46] . It cannot come from the enzymatic activities per se as neither DNMTs, nor enzymes which modify histones know which part of the genome needs to be tagged. Furthermore, there is now a large body of evidence showing that modifications of the histone tails provide signals ("binary switches") that are recognized by specific binding proteins, such as chromo-, bromoor tudor-domains which in turn can influence gene expresion and other chromatin functions 6 [47] [48] [49] . The spatial and time-dependent combinations of histone modifications further increase the complexity of information contained in chromatin [11, 48, 49] .
DNA methylation is the best-known epigenetic mark [20, 50] . It is catalyzed by two types of DNMTs: DNMT1 is a maintenance methyltransferase, whereas both DNMT3A and DNMT3B are de novo methyltransferases [51, 52] . The role of DNMT2 in DNA methylation is minor, its enzymology being largely directed to tRNA. DNA methylation is normally associated with gene inactivation and it usually occurs in CpG dinucleotides. Alternatively, DNA methylation of transcription factor binding sites which prevents binding of repressor proteins, may paradoxically induce gene activation. CpGs are normally methylated when scattered throughout the genome, but are mostly unmethylated when they are clustered as CpG islands at 5" ends of many genes. Hypermethylation of CpG-rich promoters triggers local histone code modifications resulting in a cellular camouflage mechanism that sequesters gene promoters away from transcription factors and results in stable silencing of gene expression. DNA methylation at CpG dinucleotides occurs upon transfer of Sadenosylmethionine (SAM) on cytosine by DNMTs. Whereas DNMT3A/B are responsible for DNA methylation during development (differentiation), DNMT1 is in charge of maintaining DNA methylation patterns in DNA replication during cell division. In mammalian cells, the fidelity of maintenance of methylation is 97-99.9% per mitosis, whereas de novo methylation is as high as 3-5% per mitosis, thus creating possibilities for epigenetic changes.
DNA methylation also regulates genomic imprinting [53] , Xchromosome inactivation [54] and silencing of repetitive sequences [55] . Although in most cases DNA methylation is a stable epigenetic mark, reduced levels of methylation can also be observed during development. This net loss of methylation can either occur passively by replication in the absence of cuntional maintenance methylation pathways, or actively, by removing methylated cytosines. In plants active demethylation is achieved in plants by DNA glycosylase activity, probably in combination with the base excision repair pathway. In mammals, coupling of 5-methylcytosine deaminase and thymine DNA glycosylase activities maybe responsible for DNA demethylation. Alternatively, a role for the 5-hydroxymethylcytosine modification in mammalian DNA demethylation has also been proposed as an intermediate in an active DNA demethylation pathway involving DNA repair and 5-hydroxymethylcytosine-specific DNA glycosylase activity [52] .
Although DNA methylation is the best-known epigenetic mark [51, 56, 57] , DNA methylation does not act alone. It occurs in the context of nucleosome positioning and histone modifications [9, 58, 59] . For example, high resolution DNA methylation analysis has 7 revealed 10-base periodicities (i.e one helical turn) in the DNA methylation status of nucleosome-bound DNA and found that nucleosomal DNA was more highly methylated than flanking DNA [59] . These data revealed that nucleosome positioning influences DNA methylation patterning of promoters and intron-exon boundaries throughout the genome and that DNA methyltransferases preferentially target nucleosome-bound DNA. Whether nucleosome strings provide a combinatory histone code is a matter of debate [9, 11, 12, 48, [60] [61] [62] [43, 69] . Altogether, "histone code" may only become biologically meaningful at the level of the chromatin fiber ("chromatin regulatory code") which, upon integration of conformations of multiple nucleosomes, translates allosteric changes into specific gene (cluster) activities, in order to establish specific regulatory programs at the genome level [11, [70] [71] [72] . In analogy to allosteric control of enzymes, specific gene activity may be determined by the spatial organization (compartmentalization in discrete territories) and structural landscape (three-dimensional structure) of a gene locus, by altering the higher order structure of chromatin (cis mechanism) or by generating a binding platform for effector proteins (trans mechanisms) [70, 71, 73, 74] .
There is good evidence that also noncoding RNAs regulate chromatin architecture [12, [75] [76] [77] [78] [79] [80] [75, 76, 81] . DNA-methylation can thus also be RNAdirected [12, 83] .
Inflammatory and metabolic stress fuel epigenetic plasticity
Inflammation is a fundamental adaptation to the loss of cellular and tissue homeostasis covering many important processes, including host defense, tissue remodeling and repair, and the regulation of metabolism. The complexity of the inflammatory response requires that its many functional programs are controlled coordinately in some situations but independently in others [84, 85] . This is achieved through multiple mechanisms that operate at different levels, including alterations in the composition of immune cells in tissues, changes in cell responsiveness to inflammatory stimuli, regulation of signaling pathways and epigenetic control of gene expression.
Cell-specific mechanisms operate at the level of different cell types, and include regulation of their recruitment and activation. The cellular component involves the movement of leukocytes from blood vessels into the inflamed tissue, while leukocytes are involved in the initiation and maintenance of inflammation [84, 86] . Macrophages participate in host defense, immunity and inflammatory responses, where they are potently activated resulting in the production of pro-inflammatory cytokines, oxygen and nitrogen species and eicosanoids.
Acute inflammation is mediated by granulocytes or polymorphonuclear leucocytes, while chronic inflammation is mediated by mononuclear cells such as monocytes and macrophages which can be further stimulated to maintain inflammation through the action of an adaptive cascade involving dendritic cells, T-and B-lymphocytes and antibodies [84, [87] [88] [89] [90] [91] [92] .
Imbalances in control of haematopoesis and lineage differentiation of Th1, Th2 and Treg cells have a major impact on prevalence of sensitization to allergens and allergic diseases and has M a n u s c r i p t 9 reached epidemic proportions in Western societies [93] [94] [95] [96] . Furthermore, tumors are typically infiltrated with immune cells and inflammation which impacts on most, if not all, stages of tumorigenesis [97] [98] [99] [100] . Moreover, most cancers contain an inflammatory infiltrate that is hijacked by tumor cells to promote angiogenesis, tissue invasion and cell proliferation. What is more, overnutrition and obesity activate the immune system which at long-term switches to chronic inflammatory condition that is as fertile soil for cancer development [3, [101] [102] [103] [104] [105] [106] .
Signal-specific mechanisms operate at the level of pathways which for example activate the key transcription factor nuclear factor-κB (NFκB). Among all the mediators and cellular effectors of inflammation, NFκB is perhaps the central transcription factor, which regulates expression of more than 400 genes [107] [108] [109] . At the same time, it is responsible for many aspects of inflammatory disease and malignancy by inducing transcription of soluble mediators that amplify inflammation, angiogenesis and neoplastic cell proliferation, and affect progression to more aggressive disease states [97] . called IKKε and TBK1 (TANK-binding kinase), were identified that exhibit structural similarity to IKKα and IKKβ [110] . Together, the IKKs and IKK-related kinases are instrumental for inducible activation of the host defense system and controlling metabolic stress [103, 105, 107, 111, 112] . Alternative to IKK, various additional kinases have been identified which modulate transcriptional nuclear activity of NFκB, including mitogen-and stress-activated protein kinase (MSK), protein kinase (PK)Ac, phosphoinositide 3-kinases 10 PI3K and AKT [109, [113] [114] [115] [116] . Furthermore, constitutive activity of NFκB/IKK has been observed in many cancer cells, inflammatory disorders, obesity and insulin resistance [102, 103, 105-108, 112, 117-119] . During obesity, the organism needs to adapt to and function under chronic exposure to high energy and nutrient intake. To cope with these challenges, the cell has developed the endoplasmic reticulum (ER) as a key nutrition sensor of cellular metabolic parameters (hyperglycemia, fatty acid overload, hypoglycemia, oxidative stress), which participates in viruatlly all anabolic and catabolic branches. Failure of the ER"s adaptive capacity results in activation of the unfolded protein resonse (UPR), which intersects with many different inflammatory and stress signaling pathways at the crossroad of inflammation, cancer and metabolic disease [17, 105, 106] .
Gene-specific mechanisms operate at the level of individual genes and gene subsets. Figure 2) . Similarly, p53 knockout cells reveal defects in genomic imprinting and DNA methylation regulation [153] As such, this demonstrates that and transdifferentiation of tumor-associated macrophages [120, 176] . Reports on epigenetic events in cancer are traditionally produced from analyses on "bulk" tumor samples, i.e.
without distinction between neoplastic cells on one hand and the tumoral stroma on the other.
The pro-inflammatory micro-environment that drives many tumor types is as such capable of triggering these epigenetic alterations within cancer progenitor cells, alterations which can substitute for genetic defects later in tumour progression [158, 177] . However, also tumor stromal components (which include bone-marrow-derived cells, tumor-associated macrophages) are a target of epigenetic events [92, 120, 149] . Similarly, in atherosclerotic plaques, interplay between monocytes, macrophages and vascular endothelium will trigger various epigenetic alterations in the different cell types in the plaque microenvironment [68, [178] [179] [180] [181] [182] [183] [184] [185] . Besides inflammatory factors, the micro-environment also contains free radicals produced by neutrophils, macrophages, endothelial and other cells. A c c e p t e d M a n u s c r i p t   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 14 which in turn augments the state of inflammation. In addition, reactive nitrogen intermediates such as NO and ROS, indirectly also modulate activity of epigenetic machinery which finally will affect chromatin dynamics in tumor-associated immune cells [186] [187] [188] [189] [190] .
One of the key functional characteristics of macrophages is that they can be programmed to deal most effectively with a given kind of inciting stimulus. In the lung for example, resident alveolar macrophages are continuously encountering inhaled substances due to their exposed position in the alveolar lumen [93] . To avoid collateral damage to mucosal epithelium in response to harmless antigens, they are kept in a quiescent state, producing little inflammatory cytokines and displaying poor phagocytic activity. In the vessel wall, macrophages can scavenge large amounts of lipid, and differentiate into lipid-laden foamy cells [179] . As putative precursors for microglia and osteoclasts, monocytes may also be involved in the physiology of the central nervous system and in bone remodelling. Dendritic cells (DC) are also part of the monocytic phagocytic system and are the professional antigen presenting cells of the immune system that bridge innate and adaptive immunity [91] . DC cells come in many flavours and it is clear now that there are multiple pathways to develop DC from monocytes.
The complexity of the monocytic phagocytic system requires that its many functional programmes are controlled coordinately in some situations, but separately in others. It is now clear that epigenetic mechanisms can lead to time-dependent and stimulus-specific alterations in the expresssion of functional modules [191] . Epigenetic modifications like histone modifications and CpG-island methylation in promotor regions of critical transcription factors (so called masterswitch transcription factors) of all of these functional programmes have been described and are controlled by microRNAs, DNMTs, HDAC, histone acetylases (HAT CBP/p300, p/CAF) histone lysine methylases (EZH2, CARM, PRMT) and demethylases (LSD1, JMJD3) [192, 193] . Emerging research indicates that epigenetic mechanisms that control the lineage development and polarization of monocytic phagocytic system and Th1, Th2 and Treg cells can be transmitted across multiple generations [84, 89, 194, 195] .
Smoking, diesel exhaust, diet conditions, hygiene, dust mite, obesity seem have major influence on epigenetic programming of immune cell populations and inflammatory disease severity in asthma, allergy, rheumatoid arthritis, bowel disease [196] [197] [198] [199] [200] [201] [202] . Similarly, hypertension, obesity and lack of physical activity can have longlasting effects on epigenetic reprogramming of monocytes/macrophages and endothelial cells promoting differentiation into more proatherogenic phenotypes and increased risk of cardiovascular disease [68, 180, [182] [183] [184] [185] 203] .
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Nutri-epigenomics: lifelong remodelling of our epigenomes by nutritional, phytochemical and metabolic factors
Human epidemiological studies and appropriately designed dietary interventions in animal models have provided considerable evidence to suggest that maternal nutritional imbalance and metabolic disturbances, during critical time windows of development, may have a persistent effect on the health of offspring and may even be transmitted to the next generation [29, 32, [204] [205] [206] [207] [208] . This has led to the hypothesis of ""fetal programming"" and new term ""developmental origin of health and disease"" (DOHaD): common disorders, such as obesity, cardiovascular disease (CVD), diabetes, hypertension, asthma, cancer and even schizophrenia, take root in early nutrition during gestation and continues during lactation [28, 32, [209] [210] [211] [212] [213] [214] .
The various non-Mendelian features of metabolic disease, cancer or chronic inflammatory disorders, clinical differences between men and women or monozygotic twins and fluctuations in the course of the disease are consistent with epigenetic mechanisms in the influence of fetal and/or lifelong nutrition or stochastic events on adult phenotype [29, 32, 204-208, 215, 216] . Thus, lifetime shapes the multitude of epigenomes not only within, but also across generations [29, 207] . Interest in transgenerational epigenetic effects of food components has been fueled by observations in Agouti mice fed with a soy polyphenol diet, which revealed epigenetic changes in DNA methylation patterns in their offspring and protected against diabetes, obesity and cancer across multiple generations [217] [218] [219] .
However, only weak transgenerational effects could be observed with soy polyphenols in Daphnia Magna, despite the presence of functional DNMTs [220] . Feeding pregnant mice with a diet rich in methyl donors altered DNA methylation at well defined CpG regions which led to decreased transcription of Runx3 and more sever asthma in offspring. Bronchial biopsies and alveolar macrophages of asthmatics revealed a disturbed epigenetic regulation of gene expression (increased HAT and decreased HDAC2 activity) [221] . Furthermore, the honeybee (Apis mellifera) is probably the clearest example of induction of alternative phenotypes and epigenotypes by nutrition in early life [222] . Female bees are genetic clones.
However, queens are distinct from workers in their morphology, capacity to reproduce, behavior, and longevity. The difference between the queen and worker castes lies in the exposure of the genetically identical larvae to royal jelly, an as yet incompletely defined mixture of proteins, amino acids, vitamins, lipids, and other nutrients [223] [224] [225] . [68, 183, [247] [248] [249] . In a proatherogenic murine model, DNA-methylation polymorphisms preceded the appearance of histological signs of atherosclerosis [181, 182] . Interestingly, involvement of the inducible 17 JMJD3 demethylase was demonstrated to regulate monocyte/macrophage transdifferentiation programs, illustrating that developmental programs are plastic and monocyte lineage differentiation is susceptible to inflammatory pathways and oxidative stress [120] . A role for the JMJD1A demethylase was demonstrated in metabolic gene expression and obesity resistance [250] . Furthermore, it was found that knockdown of the LSD1 demethylase affected monocyte adherence in a proatherogenic diabetic mouse model [251] . This suggests that LSD1 contribute to metabolic memory through long-term changes in gene expression via alterations in chromatin structure [146, 252] .
Poor maternal nutrition has also been associated with increased risk of type 2 diabetes mellitus over several generations in North American Indians [253, 254] . Individuals with metabolic syndrome, obesity and type II diabetes (T2D) CVD may show a lifelong imbalance between energy intake and energy expenditure due to incorrect epigenetic programming during their early development as a result of placental insufficiency, inadequate maternal nutrition, metabolic disturbances or neonatal medication [205, [253] [254] [255] [256] [257] [258] .
Recently, evidence emerged that also timing (preconception, pregnancy, lactation, neonatal life, early life, pre-/post-menopause, puberty) of various dietary exposures may be vitally important in determining health beneficial effects, as epigenetic plasticity changes continually from conception to death [259] . In principle; epigenetic changes occurring during embryonic development will have a much greater impact on the overall epigenetic status of the organism because, as they can be transmitted over consecutive mitotic divisions, alterations occurring in single embryonic stem cells will affect many more cells than those occurring in adult stem and /or somatic cells during postnatal development [206] . Epigenetic plasticity further also depends on other processes such as chromosomal instability, telomere shortening, metabolic cycles, mitochondrial deteriorations, and oscillatory, circadian or seasonal rhythms of systemic hormone levels (hypothalamic-pituitary-adrenal (HPA) axis) [28] [29] [30] [258] [259] [260] [261] [262] . In addition to epigenetic imprinting during crucial periods of development, stochastic or genetically and environmentally triggered epigenomic changes (epimutations) occur day after day and accumulate over time, as maximal differences in DNA methylation profiles are observed in aged monozygotic twins with a history of non-shared environments [6, 8] .
Concerning nutritional transgenerational inheritance there is increasing evidence in both plants and animals that, following nutritional intervention (caloric, iron and protein restriction, polyphenol-, folate-, micronutrient-, fat-or carbohydrate-rich diet), maternal diabetes, during pregnancy and lactation can affect the following generation(s) [38, 207, 211, 218, 219, 263, 264] . Although it has long been thought that the epigenomic profile is wiped 18 clean in the embryo shortly after fertilization, with the exception of imprinted genes, methylation clearing is not complete after fertilization and on a global DNA level is reduced to 10% [265, 266] . Alternatively, it can not be excluded that transgenerationally inherited nutritional effects may also depend on polycomb proteins [207, [267] [268] [269] , miRNA profiles [12, 270] or epigenetic capacitor properties of hsp proteins [271] [272] [273] .
A next challenge will be to determine which adverse epigenomic marks are reversible by specific diets, drugs or lifestyle changes [29, 32, 38, 259] . Numerous botanical species and plant parts contain a diverse array of polyphenolic phytochemicals which exert healthbeneficial effects in man by its anti-inflammatory, anti-oxidant, phytohormone, cardioprotective, cancer preventive and anti-bacterial properties, by maintaining immune homeostasis (hormesis) [274, 275] . Phytochemicals have also succesfully been applied for regenerative medicine and cancer stem cell therapy [173, [276] [277] [278] [279] [280] . "epigenetics" sheds a more realistic light on dietary studies, as longlife exposure at physiological concentrations can remodel the epigenome in a cumulative fashion by repetitive effects on the epigenetic machinery [241, [288] [289] [290] [291] . Particular attention needs to be given to natural compounds which can trigger opposite effects on HDAC/HAT/DNMT or histone (de)methylase (H(D)MT) depending on the concentration or cell type-specific metabolisation [34, 35] . It should also be stressed that it is not known whether all of them can be considered authentic epigenetic modifiers because it has not yet been demonstrated whether the epigenetic modifications that they induce are stable over time. Interestingly, even transient exposure to a specific dietary component can induce long-lasting epigenetic changes in the promoter of the NFB subunit p65, which acts as a master switch in inflammatory gene expression [146] . Alternatively, compounds may chemically interfere with histone mark interacting effector domains (such as chromo-, bromo-or tudor domains) [47, 292, 293] .
However, one should be careful with interpretation of in vitro compound screenings or cofactor activity assays based on peptide-protein interactions, as this may not always represent true targets in vivo [294, 295] .
Besides specific interference of the diet with chromatin modifying enzymes and DNMTs at particular target genes, global epigenetic changes can also occur following biochemical metabolisation of dietary factors, which can deplete cellular pools of acetyl-CoA, NAD + and methyldonors, resulting in unbalanced DNA methylation and/or protein acetylation or methylation [282, 296, 297] . For example diets lacking in substrate or cofactors in methyldonormetabolism can contribute to DNA hypomethylation by impairing synthesis of SAM [234] . This methylation cycle is frequently cited to explain relations between diet and epigenetic changes [233, 298] . However, even without nutritional deficiency of methyl groups, impaired synthesis of SAM and perturbed DNA methylation can happen when the need for the synthesis of the detoxification enzyme glutathione transferase (GSH) synthesis A c c e p t e d M a n u s c r i p t   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   20 increases [299] . Diets or nutritional compounds which affect energy metabolism or mitochondrial respiration can have global epigenetic effects upon changes in NAD + availability and SIRT activity [300] . Since SIRT activation has been linked to longevity (increased lifespan and healthy aging) and mimics a caloric restricted diet, SIRT activators such as resveratrol represent a major class of caloric mimetic epigenetic modulator phytochemicals which could reverse metabolic disease [297] .
Conclusion
The Hippocrates said already 25 centuries ago. As such, it will be a challenge for future antiinflammatory therapeutics and preventive cancer research to identify novel epigenetic targets which allow selective modulation of the inflammatory signaling network in the diseased tissue and/or microenvironment [275, [301] [302] [303] [304] [305] [306] . Given several encouraging trials, prevention and therapy of age-and lifestyle-related diseases by individualised tailoring of optimal epigenetic diets or supplements are conceivable. However, these interventions will require intense efforts to unravel the complexity of these epigenetic, genetic and environment interactions. Another goal is to evaluate their potential reversibility with minimal side effects as diet components may reprogram malignant cells as well as the host immune system and HPA-axis depending on the bioavailability of the dietary compounds [32, 133, 149, 150, 289, 291] (See Figure 3) . There is some concern that epigenetic therapy with dietary inhibitors of DNMT, HDAC, histon(de)methylases in longterm treatment setups may suffer from lack of specificity [283, 292, 294] . As such, the possible alternative is to combine nonselective A c c e p t e d M a n u s c r i p t   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   21 epigenetic therapies with more targeted approaches [46] . For example, combined treatment of specific transcription factor inhibitors and/or hormone receptor ligands with epigenetic drugs may trigger synergistic activities at subsets of inflammatory genes [43, 46, [307] [308] [309] . An excellent example of cooperation between a dietary vitamin A-derivative targeting a nuclear receptor and the HDAC inhibitor butyrate has been described in the treatment of acute promyelocytic leukemias [33] . Finally, microRNA and long ncRNA pathways also hold promise to join soon the arsenal of epigenetic combination therapies, as their target sequence specificity may bridge the gap between genetic and epigenetic changes [12, [79] [80] [81] . In conclusion, studies are revealing a dazzling complexity in the mechanisms leading to dynamic alterations of the epigenome and the need of combination therapies targeting different chromatin modifiers, to reverse disease prone epigenetic alterations to preserve healthy aging.
Medical benefits of dietary compounds as epigenetic modulators, especially with respect to their chronic use as nutraceutical agents, will rely on our further understanding of their epigenetic effects during embryogenesis, early life, aging as well as through different generations.
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Figure 1
Interplay of inflammatory and metabolic stress pathways in nutritional epigenetic effects in lifestyle diseases. mut, mutation; SNP, single nucleotide polymorphism; miR, microRNA, ncRNA, noncoding RNA.
Figure 2
Working model illustrating crosstalk of inflammatory and metabolic stress pathways with epigenetic regulation in the nucleus. For example, transcription of the highly conserved IL6
gene promoter requires binding of activator protein AP1, CREB and nuclear factor NFB transcription factors in response to various stimuli [310, 311] , with strict stereospecific requirements for optimal cofactor recruitment, promoting a promoter enhanceosome model with multiple transcription factor/cofactor interactions, in which NFB is the primary trigger for IL6 gene induction in response to TNF. Inflammatory stimuli (i.e. TNF, virus, bacteria) or metabolic stress (including oxidative stresss, endoplasmic reticulum (ER) stress or unfolded protein response (UPR) stress, for example during obesity or malnutrition) can activate the IKK-complex, responsible for IB-phosphorylation, which allows NFB to translocate to the nucleus, following degradation of IB in the proteasome. IL6 gene expression also requires activation and recruitment of the mitogen-and stress-activated protein kinase-1 (MSK1) to elicit selective chromatin relaxation at the IL6 gene promoter, upon phosphorylation of NFB p65 S276 and histone H3 S10, followed by further CBP/p300 recruitment and HATdependent acetylation of the IL6 promoter enhanceosome/chromatin environment [115] .
Highly elevated expression levels of AP1 Fra1 and NFB in ER-deficient tumor cells increase chromatin accessibility (DNA hypersensitive sites) in the proximal IL6 gene promoter. Of particular interest, dietary anti-inflammatory phytochemicals such as soy polyphenol genistein [149, 150, 274] and withanolide withaferin A [312] are able to silence the highly promiscuous IL6 promoter nucleosome configuration by lowering the cellular amounts of Fra1 and NFB activity, concomitantly with decreased histone H3 phosphoacetylation levels and increased DNA methylation [133, 149, 150] . Flowchart which summarizes the complex and multilayered regulation of nutritional epigenetic effects.
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